人类中和抗体对抗SARS-CoV-2需要完整的Fc效应功能以获得最佳的治疗保护

Emma S Winkler1, Pavlo Gilchuk2, Jinsheng Yu3

  • 1Department of Medicine, Washington University School of Medicine, St. Louis, St. Louis, MO 63110, USA; Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, St. Louis, MO 63110, USA.

Cell
|March 10, 2021
PubMed
概括

中和单克隆抗体 (mAbs) 抗击SARS-CoV-2感染. 完整的mAbs对于治疗至关重要,使用Fc效应器功能通过激活单细胞和CD8+T细胞来减少炎症和肺部疾病.